Cargando…

Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function

BACKGROUND: Elevated levels of osteoprotegerin (OPG) have been associated with adverse outcomes in ST-elevation myocardial infarction (STEMI). However, the role of OPG in myocardial injury and adverse remodeling in STEMI patients remains unclear. The aims of this observational cohort study were to e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shetelig, Christian, Limalanathan, Shanmuganathan, Eritsland, Jan, Hoffmann, Pavel, Seljeflot, Ingebjørg, Gran, Jon Michael, Aukrust, Pål, Ueland, Thor, Andersen, Geir Øystein
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333871/ https://www.ncbi.nlm.nih.gov/pubmed/28253327 http://dx.doi.org/10.1371/journal.pone.0173034

Ejemplares similares

Evaluation of circulating levels of CCN2/connective tissue growth factor in patients with ST-elevation myocardial infarction
por: Ritschel, Vibeke, et al.
Publicado: (2017)

Effect of Ischemic Postconditioning on Infarct Size in Patients With ST‐Elevation Myocardial Infarction Treated by Primary PCI Results of the POSTEMI (POstconditioning in ST‐Elevation Myocardial Infarction) Randomized Trial
por: Limalanathan, Shanmuganathan, et al.
Publicado: (2014)

Association of Interleukin 8 and Myocardial Recovery in Patients with ST-Elevation Myocardial Infarction Complicated by Acute Heart Failure
por: Husebye, Trygve, et al.
Publicado: (2014)

Neutrophil Extracellular Trap Components Associate with Infarct Size, Ventricular Function, and Clinical Outcome in STEMI
por: Helseth, Ragnhild, et al.
Publicado: (2019)

Glucose associated NETosis in patients with ST-elevation myocardial infarction: an observational study
por: Helseth, Ragnhild, et al.
Publicado: (2019)

Myocardial Salvage is Reduced in Primary PCI-Treated STEMI Patients with Microvascular Obstruction, Demonstrated by Early and Late CMR
por: Limalanathan, Shanmuganathan, et al.
Publicado: (2013)

Markers of Thrombin Generation Are Associated With Long-Term Clinical Outcome in Patients With ST-Segment Elevation Myocardial Infarction
por: Hansen, Charlotte Holst, et al.
Publicado: (2018)

High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI
por: Tøllefsen, Ingvild Maria, et al.
Publicado: (2021)

MR findings of microvascular perfusion in infarcted and remote myocardium early after successful primary PCI
por: Bethke, Anne, et al.
Publicado: (2018)

IgM antibodies against phosphorylcholine measured early after acute ST-elevation myocardial infarction in relation to atherosclerotic disease burden and long-term clinical outcome
por: Knudsen, Eva Cecilie, et al.
Publicado: (2019)

Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients
por: Knudsen, Eva C, et al.
Publicado: (2009)

Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction
por: Helseth, Ragnhild, et al.
Publicado: (2021)

Circulating Levels of IL‐6 Receptor and gp130 and Long‐Term Clinical Outcomes in ST‐Elevation Myocardial Infarction
por: Ritschel, Vibeke N., et al.
Publicado: (2016)

Double-Stranded DNA and NETs Components in Relation to Clinical Outcome After ST-Elevation Myocardial Infarction
por: Langseth, Miriam Sjåstad, et al.
Publicado: (2020)

Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI)
por: Anstensrud, Anne Kristine, et al.
Publicado: (2019)

Impact of newly diagnosed abnormal glucose regulation on long-term prognosis in low risk patients with ST-elevation myocardial infarction: A follow-up study
por: Knudsen, Eva C, et al.
Publicado: (2011)

Postconditioning in ST-elevation myocardial infarction: a systematic review, critical appraisal, and meta-analysis of randomized clinical trials
por: Abdelnoor, M, et al.
Publicado: (2014)

Cytokine pattern in patients with ST-elevation myocardial infarction treated with the interleukin-6 receptor antagonist tocilizumab
por: Woxholt, Sindre, et al.
Publicado: (2023)

Markers of thrombin generation are associated with myocardial necrosis and left ventricular impairment in patients with ST-elevation myocardial infarction
por: Hansen, C. H., et al.
Publicado: (2015)

Activin A Levels Are Associated With Abnormal Glucose Regulation in Patients With Myocardial Infarction: Potential Counteracting Effects of Activin A on Inflammation
por: Andersen, Geir Ø., et al.
Publicado: (2011)

Neutrophil extracellular trap components and myocardial recovery in post-ischemic acute heart failure
por: Langseth, Miriam Sjåstad, et al.
Publicado: (2020)

Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial
por: Huse, Camilla, et al.
Publicado: (2022)

The Time Profile of Pentraxin 3 in Patients with Acute ST-Elevation Myocardial Infarction and Stable Angina Pectoris Undergoing Percutaneous Coronary Intervention
por: Helseth, Ragnhild, et al.
Publicado: (2014)

Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarction
por: Ueland, Thor, et al.
Publicado: (2018)

IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction
por: Orrem, Hilde L., et al.
Publicado: (2018)

The Influence of Autologous Bone Marrow Stem Cell Transplantation on Matrix Metalloproteinases in Patients Treated for Acute ST-Elevation Myocardial Infarction
por: Furenes, Eline Bredal, et al.
Publicado: (2014)

Novel Insights Into the Effects of Interleukin 6 Antagonism in Non–ST‐Segment–Elevation Myocardial Infarction Employing the SOMAscan Proteomics Platform
por: George, Marc J., et al.
Publicado: (2020)

Acute heart failure following myocardial infarction: complement activation correlates with the severity of heart failure in patients developing cardiogenic shock
por: Orrem, Hilde L., et al.
Publicado: (2018)

Increased levels of CRP and MCP-1 are associated with previously unknown abnormal glucose regulation in patients with acute STEMI: a cohort study
por: Knudsen, Eva C, et al.
Publicado: (2010)

Osteoprotegerin and Myocardial Fibrosis in Patients with Aortic Stenosis
por: Loudon, Brodie L., et al.
Publicado: (2018)

Prevalence of risk factors at presentation and early mortality in patients aged 80 years or older with ST-segment elevation myocardial infarction
por: Claussen, Peter Andreas, et al.
Publicado: (2014)

Non-ST Segment Elevation Myocardial Infarction Associated With Cocaine Use
por: Choksey, Ishan, et al.
Publicado: (2022)

Tombstoning ST-Elevation Myocardial Infarction
por: Balci, Bahattin
Publicado: (2009)

ST Elevation Myocardial Infarction in the elderly
por: Franken, Marcelo, et al.
Publicado: (2012)

Mistaken ST-Elevation Myocardial Infarction
por: Wolk, Brian J.
Publicado: (2015)

Rabies Encephalitis With Myocarditis Mimicking ST-Elevation Myocardial Infarction
por: Park, Stacy C, et al.
Publicado: (2019)

Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease
por: Franczyk-Skóra, Beata, et al.
Publicado: (2013)

Lysophospholipids as Predictive Markers of ST-Elevation Myocardial Infarction (STEMI) and Non-ST-Elevation Myocardial Infarction (NSTEMI)
por: Chorell, Elin, et al.
Publicado: (2020)

Serum Fatty Acids, Traditional Risk Factors, and Comorbidity as Related to Myocardial Injury in an Elderly Population with Acute Myocardial Infarction
por: Laake, Kristian, et al.
Publicado: (2016)

Circulating PCSK9 and Risk of Myocardial Infarction: The HUNT Study in Norway
por: Laugsand, Lars E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mnkigcn6maqq61m5mavjrtpjls